We confirmed an association between these detrimental events and a defective intestinal FXR pathway, which has been acknowledged in models of IBD and cirrhosis as enteroprotective, both in terms of maintaining structural integrity and counter-regulating excessive local inflammatory events [8–10,13,34,36]. Here, NR1H4 is linked to inflammatory bowel disease.